In the work of Liang et al. [12], the authors performed a Kaplan–Meier analysis to estimate the recurrence-free survival of breast cancer patients belonged to different molecular subtypes and grouped into different subsamples with respect to both a low/high expression of ki67 and a different tumor grading. This evidence concerns the gene MKI67 and breast cancer.